Personne : Hachicha, Zeineb
En cours de chargement...
Adresse électronique
Date de naissance
Projets de recherche
Structures organisationnelles
Fonction
Nom de famille
Hachicha
Prénom
Zeineb
Affiliation
Institut universitaire de cardiologie et de pneumologie de Québec - Université Laval
ISNI
ORCID
Identifiant Canadiana
ncf11892627
person.page.name
1 Résultats
Résultats de recherche
Voici les éléments 1 - 1 sur 1
Publication Restreint B-type natriuretic peptide in low-flow, low-gradient aortic stenosis : relationship to hemodynamics and clinical outcome : results from the Multicenter Truly or Pseudo-Severe Aortic Stenosis (TOPAS) study.(American Heart Association, 2007-06-05) Bergler-Klein, Jutta; Fuchs, Christina; Mundigler, Gerald; Mohty, Dania; Hachicha, Zeineb; Burwash, Ian G.; Blais, Claudia; Pibarot, Philippe; Dumesnil, Jean G.; Beanlands, Robert S. B.; Walter-Publig, Nicole; Rader, Florian; Baumgartner, HelmutBACKGROUND: The prognostic value of B-type natriuretic peptide (BNP) is unknown in low-flow, low-gradient aortic stenosis (AS). We sought to evaluate the relationship between AS and rest, stress hemodynamics, and clinical outcome. METHODS AND RESULTS: BNP was measured in 69 patients with low-flow AS (indexed effective orifice area < 0.6 cm2/m2, mean gradient < or = 40 mm Hg, left ventricular ejection fraction < or = 40%). All patients underwent dobutamine stress echocardiography and were classified as truly severe or pseudosevere AS by their projected effective orifice area at normal flow rate of 250 mL/s (effective orifice area < or = 1.0 cm2 or > 1.0 cm2). BNP was inversely related to ejection fraction at rest (Spearman correlation coefficient r(s)=-0.59, P<0.0001) and at peak stress (r(s)=-0.51, P<0.0001), effective orifice area at rest (r(s)=-0.50, P<0.0001) and at peak stress (r(s)=-0.46, P=0.0002), and mean transvalvular flow (r(s)=-0.31, P=0.01). BNP was directly related to valvular resistance (r(s)=0.42, P=0.0006) and wall motion score index (r(s)=0.36, P=0.004). BNP was higher in 29 patients with truly severe AS versus 40 with pseudosevere AS (median, 743 pg/mL [Q1, 471; Q3, 1356] versus 394 pg/mL [Q1, 191 to Q3, 906], P=0.012). BNP was a strong predictor of outcome. In the total cohort, cumulative 1-year survival of patients with BNP > or = 550 pg/mL was only 47+/-9% versus 97+/-3% with BNP < 550 (P<0.0001). In 29 patients who underwent valve replacement, postoperative 1-year survival was also markedly lower in patients with BNP > or = 550 pg/mL (53+/-13% versus 92+/-7%). CONCLUSIONS: BNP is significantly higher in truly severe than pseudosevere low-gradient AS and predicts survival of the whole cohort and in patients undergoing valve replacement.